Search Results for “E_S4HCON2023 Übungsmaterialien – E_S4HCON2023 Lernführung: SAP Certified Technology Specialist – SAP S/4HANA Conversion and SAP System Upgrade – E_S4HCON2023 Lernguide ♿ Suchen Sie auf ⏩ www.itzert.com ⏪ nach 《 E_S4HCON2023 》 und erhalten Sie den kostenlosen Download mühelos 🕑E_S4HCON2023 Online Prüfung” – Page 30

Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria

284	Stull, D.+, McBride, D., Tian, H., Giménez-Arnau, A., Maurer, M. Marsland, A., Balp, M. M., Khalil, S., and Grattan, C.: Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria. Brit. J. Dermatol. 2017: 177; 1093-1101. IF: 6.13

345	Krause, K., Sabat, R., Witte-Händel, E., Schulze, A., Puhl, V., Maurer, M., and Wolk, K.+: Association of CCL2 with systematic inflammation in Schnitzler syndrome. Br. J. Dermatol. 2019: 180; 859-868. IF: TBD (IF 2018: 6.71)

271	Krause, K., Tsianakas, A., Wagner, N., Fischer, J., Weller, K., Metz, M., Church, M. K., and Maurer, M.:Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study. J. Allergy Clin. Immunol. 2017: 139; 1311-1320. IF: 13.26

144	Konstantinou, G. N., Asero, R., Ferrer, M., Knol, E. F., Maurer, M. Raap, U., Schmid-Grendelmeier, P., Skol, P. S., and Grattan, C. E. H.+: EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 2013: 68; 27-36. IF: 5.99

265	Weller, K.+, Maurer, M. Fridman, M., Supina, D., Schranz, J., and Magerl, M.: Health-related quality of life in hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase. Allergy Asthma Proc. 2017: 38; 143-151. IF: 2.21

262	Weller, K.+, Magerl, M., Peveling-Oberhag, A., Martus, P., Staubach, P., and Maurer, M.: The angioedema quality of life questionnaire (AE-QoL) – assessment of sensitivity to change and minimal clinically important difference. Allergy 2016: 71; 1203-1209. IF: 7.36

416.	Matanis, L., Eiza, N., Sabag, A., Bejar, J., Giménez-Arnau, A. M., Maurer, M., and Vadasz, Z.⁺: The expression of IL-17, in chronic spontaneous urticaria is linked to semaphorin5A. Biomolecules 2021: 11; 373. IF: 6.06

o.416

155	Młynek, A., Vieira dos Santos, R., Ardelean, E., Weller, K., Magerl, M., Church, M. K., and Maurer, M.+: A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism. Clin. Exp. Dermatol. 2013: 38; 360-366. IF: 1.23

o.155

322	Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: The urticaria activity score – validity, reliability, and responsiveness. J. Allergy Clin. Immunol. Pract. 2018: 6; 1185-1190. IF: 7.55

A simulated car-driving study on the effects of acute administration of levocetirizine, fexofenadine, and diphenhydramine in healthy Japanese volunteers

235

Inami, A., Matsuda, R., Grobosch, T., Komamura, H., Takeda, K., Yamada, Y., Miyake, M., Hiraoka, K., Maurer, M. Yanai, K., and Tashiro, M.+: A simulated car-driving study on the effects of acute administration of levocetirizine, fexofenadine, and diphenhydramine in healthy Japanese volunteers. Hum. Psychopharmacol. Clin. Exp. 2016: 31; 167-177. IF: 2.21